Savara: Latest News, Top Stories & Analysis - Page 3 of 3

LANGHORNE, PA — In a significant advancement for patients suffering from autoimmune Pulmonary Alveolar Proteinosis (aPAP), Savara Inc. has revealed promising outcomes from its IMPALA-2 Phase 3 clinical trial. The …

Regional

Savara Inc. Eyes Future Growth with Ongoing IMPALA-2 Trial and Strategic Investments

May 14, 2024May 14, 2024 - by Timothy Alexander

LANGHORNE, PA — Biopharmaceutical company Savara Inc. (Nasdaq: SVRA) disclosed its financial outcomes for the first quarter ended March 31, 2024, while casting an optimistic glance towards its pipeline’s progress …